Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × OTHER × molgramostim × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

Magnetic Resonance Spectroscopy 50 Cyclophosphamide 37 pembrolizumab 32 Radiotherapy 27 fludarabine 23 Biopsy 23 Nivolumab 20 Metformin 19 Fluorodeoxyglucose F18 19 Bevacizumab 18 Specimen Handling 17 Radiosurgery 13 Temozolomide 12 Cisplatin 12 durvalumab 11 Dexamethasone 11 Carboplatin 11 gallium 68 PSMA-11 10 Paclitaxel 10 Fluorouracil 10 X-Rays 9 Standard of Care 9 Radiation 9 Letrozole 9 Ipilimumab 9 Immunotherapy, Adoptive 9 Gemcitabine 9 Etoposide 9 Doxorubicin 9 olaparib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡